Okolie Charles E, Wooldridge Karl G, Turner David P, Cockayne Alan, James Richard
Centre for Healthcare Associated Infections, Centre for Biomolecular Sciences Building, University of Nottingham, University Park, Nottingham NG7 2RD, United Kingdom.
Centre for Healthcare Associated Infections, Centre for Biomolecular Sciences Building, University of Nottingham, University Park, Nottingham NG7 2RD, United Kingdom.
Mol Cell Probes. 2015 Jun;29(3):144-50. doi: 10.1016/j.mcp.2015.03.002. Epub 2015 Mar 16.
Staphylococcus aureus strains harbouring genes encoding virulence and antibiotic resistance are of public health importance. In clinical samples, pathogenic S. aureus is often mixed with putatively less pathogenic coagulase-negative staphylococci (CoNS), both of which can harbour mecA, the gene encoding staphylococcal methicillin-resistance. There have been previous attempts at distinguishing MRSA from MRCoNS, most of which were based on the detection of one of the pathognomonic markers of S. aureus, such as coa, nuc or spa. That approach might suffice for discrete colonies and mono-microbial samples; it is inadequate for identification of clinical specimens containing mixtures of S. aureus and CoNS. In the present study, a real-time pentaplex PCR assay has been developed which simultaneously detects markers for bacteria (16S rRNA), coagulase-negative staphylococcus (cns), S. aureus (spa), Panton-Valentine leukocidin (pvl) and methicillin resistance (mecA). Staphylococcal and non-staphylococcal bacterial strains (n = 283) were used to validate the new assay. The applicability of this test to clinical samples was evaluated using spiked blood cultures (n = 43) containing S. aureus and CoNS in mono-microbial and poly-microbial models, which showed that the 5 markers were all detected as expected. Cycling completes within 1 h, delivering 100% specificity, NPV and PPV with a detection limit of 1.0 × 10(1) to 3.0 × 10(1) colony forming units (CFU)/ml, suggesting direct applicability in routine diagnostic microbiology. This is the most multiplexed real-time PCR-based PVL-MRSA assay and the first detection of a unique marker for CoNS without recourse to the conventional elimination approach. There was no evidence that this new assay produced invalid/indeterminate test results.
携带编码毒力和抗生素抗性基因的金黄色葡萄球菌菌株具有公共卫生重要性。在临床样本中,致病性金黄色葡萄球菌常与假定致病性较低的凝固酶阴性葡萄球菌(CoNS)混合存在,二者都可能携带mecA基因,该基因编码葡萄球菌对甲氧西林的抗性。此前曾尝试区分耐甲氧西林金黄色葡萄球菌(MRSA)和耐甲氧西林凝固酶阴性葡萄球菌(MRCoNS),其中大多数基于检测金黄色葡萄球菌的一种特征性标志物,如coa、nuc或spa。该方法对于离散菌落和单微生物样本可能足够;但对于鉴定含有金黄色葡萄球菌和CoNS混合物的临床标本则不够。在本研究中,开发了一种实时五重PCR检测方法,可同时检测细菌(16S rRNA)、凝固酶阴性葡萄球菌(cns)、金黄色葡萄球菌(spa)、杀白细胞素(pvl)和甲氧西林抗性(mecA)的标志物。使用葡萄球菌和非葡萄球菌菌株(n = 283)对新检测方法进行验证。在单微生物和多微生物模型中,使用添加了金黄色葡萄球菌和CoNS的血培养物(n = 43)评估该检测方法对临床样本的适用性,结果表明所有5种标志物均按预期检测到。循环在1小时内完成,特异性、阴性预测值和阳性预测值均为100%,检测限为1.0×10¹至3.0×10¹菌落形成单位(CFU)/ml,表明可直接应用于常规诊断微生物学。这是基于实时PCR的最多重的PVL-MRSA检测方法,也是首次无需采用传统排除方法即可检测CoNS独特标志物的方法。没有证据表明这种新检测方法会产生无效/不确定的检测结果。